IL10 and psoriasis: A further study on psoriasis patients undergoing IL-10 therapy confirmed induction of systemic neopterin by IL-10 and demonstrated enhanced ex vivo NK cell-derived IFNγ production by cells obtained from cytokine-treated patients.